Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The homocysteine metabolism pathway refers to the biochemical processes by which the sulfur-containing amino acid homocysteine is synthesized, utilized, and degraded in the body. Homocysteine is not obtained directly from the diet but is produced as an intermediate during methionine metabolism. Its levels are tightly regulated due to its association with vascular and neurological diseases when elevated. The pathway involves remethylation of homocysteine to methionine (using folate/B12 or betaine) and transsulfuration to cysteine (using vitamin B6).
Folic acid, Vitamin B12, and Vitamin B6 act as cofactors for enzymes within the pathway, supporting homocysteine remethylation or transsulfuration. Betaine donates a methyl group to homocysteine, facilitating remethylation to methionine.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Homocysteine Metabolism Pathway (HMP).